Ysios Capital
Investor profile
Investment firm
Deals
24
distinct rounds
Companies
20
backed
Active span
2009–2026
18 yrs
Total round €
€968M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Gilde Healthcare5
- Caixa Capital Risc4
- Asabys Partners3
- Bpifrance3
- Columbus Venture Partners3
- Kurma Partners3
- Novartis Venture Fund3
- Edmond de Rothschild Venture Capital2
- Forbion2
- GIMV2
- IDInvest Partners2
- Innogest Capital2
- Jeito Capital2
- M Ventures2
- New Enterprise Associates2
- Novo Seeds2
- Roche Venture Fund2
- Seventure Partners2
- Sofinnova Partners2
- Sunstone Capital2
- UCB Ventures2
- 4BIO Capital1
- Abbvie Biotech Ventures1
- ALSA Ventures1
- Alta Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| SpliceBio | Spain | 2 | €168M |
| Galecto Biotech | Denmark | 1 | €79M |
| Sparingvision | France | 1 | €75M |
| Ona Therapeutics | Spain | 1 | €74M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| Minoryx Therapeutics | Spain | 2 | €70M |
| Endosense | Switzerland | 2 | €69M |
| ReproNovo | Switzerland | 1 | €57M |
| Xeltis | Switzerland | 1 | €45M |
| Vivet Therapeutics | France | 1 | €38M |
| Sanifit | Spain | 1 | €37M |
| Medlumics | Spain | 1 | €34M |
| OxThera | Sweden | 1 | €32M |
| BioVex | UK | 1 | €27M |
| STAT-Diagnostica | Spain | 2 | €27M |
| Memo Therapeutics | Switzerland | 1 | €20M |
| Corwave | France | 1 | €16M |
| Anaconda Biomed | Spain | 1 | €15M |
| AM-Pharma | Netherlands | 1 | €12M |
| Inbiomotion | Spain | 1 | €2.4M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| SpliceBio | Series B | €118M | 2025-06 |
| Galecto Biotech | Series C | €79M | 2018-09 |
| Sparingvision | Series B | €75M | 2022-09 |
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| ReproNovo | Series A | €57M | 2025-05 |
| Minoryx Therapeutics | Series C | €51M | 2022-05 |
| SpliceBio | Series A | €50M | 2022-02 |
| Xeltis | Series C | €45M | 2017-03 |
| Vivet Therapeutics | Series A | €38M | 2017-05 |